Avestar Capital, LLC Halozyme Therapeutics, Inc. Transaction History

Avestar Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$38.84 - $51.31 $773,731 - $1.02 Million	-19,921 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$39.51 - $51.45 $296,996 - $386,749	7,517 Added 60.6%	19,921 $1.02 Million
Q4 2020 Feb 01, 2021	BUY	$25.81 - $43.62 $124,688 - $210,728	4,831 Added 63.79%	12,404 $530,000
Q3 2020 Oct 29, 2020	BUY	$25.74 - $29.63 $194,929 - $224,387	7,573 New	7,573 $233,000

442

122M

216K

140K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.24B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.